Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/177945
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMartínez-Peinado, Nieves-
dc.contributor.authorCortés Serra, Núria-
dc.contributor.authorTorras Claveria, Laura-
dc.contributor.authorPinazo, Maria-Jesus-
dc.contributor.authorGascón i Brustenga, Joaquim-
dc.contributor.authorBastida Armengol, Jaume-
dc.contributor.authorAlonso Padilla, Julio-
dc.date.accessioned2021-06-03T08:03:17Z-
dc.date.available2021-06-03T08:03:17Z-
dc.date.issued2020-
dc.identifier.issn1756-3305-
dc.identifier.urihttp://hdl.handle.net/2445/177945-
dc.description.abstractBackground: Chagas disease, caused by the protozoan Trypanosoma cruzi, is a neglected disease that afects ~7 million people worldwide. Development of new drugs to treat the infection remains a priority since those currently available have frequent side efects and limited efcacy at the chronic stage. Natural products provide a pool of diver sity structures to lead the chemical synthesis of novel molecules for this purpose. Herein we analyzed the anti-T. cruzi activity of nine alkaloids derived from plants of the family Amaryllidaceae. Methods: The activity of each alkaloid was assessed by means of an anti-T. cruzi phenotypic assay. We further evalu ated the compounds that inhibited parasite growth on two distinct cytotoxicity assays to discard those that were toxic to host cells and assure parasite selectivity. Results: We identifed a single compound (hippeastrine) that was selectively active against the parasite yielding selectivity indexes of 12.7 and 35.2 against Vero and HepG2 cells, respectively. Moreover, it showed specifc activity against the amastigote stage (IC50=3.31 μM). Conclusions: Results reported here suggest that natural products are an interesting source of new compounds for the development of drugs against Chagas disease. Keywords: Chagas disease, Trypanosoma cruzi, Alkaloids, Amaryllidaceae, Hippeastrine, Phenotypic assays, Cytotoxicity-
dc.format.extent10 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherBioMed Central-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/s13071-020-04171-6-
dc.relation.ispartofParasites & Vectors, 2020, vol. 13, num. 299, p. 1-10-
dc.relation.urihttps://doi.org/10.1186/s13071-020-04171-6-
dc.rightscc-by (c) Martínez-Peinado, Nieves et al., 2020-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.sourceArticles publicats en revistes (Biologia, Sanitat i Medi Ambient)-
dc.subject.classificationMalaltia de Chagas-
dc.subject.classificationMarcadors bioquímics-
dc.subject.classificationAlcaloides-
dc.subject.otherChagas' disease-
dc.subject.otherBiochemical markers-
dc.subject.otherAlkaloids-
dc.titleAmaryllidaceae alkaloids with anti-Trypanosoma cruzi activity-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec708605-
dc.date.updated2021-06-03T08:03:17Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (ISGlobal)
Articles publicats en revistes (Biologia, Sanitat i Medi Ambient)

Files in This Item:
File Description SizeFormat 
708605.pdf1.67 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons